Regeneron Pharmaceuticals
REGN
#320
Rank
A$109.99 B
Marketcap
A$1,068
Share price
0.94%
Change (1 day)
21.37%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Net assets

Net assets on the balance sheet as of June 2026 : A$45.38 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company has A$45.38 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Regeneron Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$46.66 B-1.12%
2024-12-31$A$47.19 B23.79%
2023-12-31$A$38.12 B14.47%
2022-12-31$A$33.30 B28.65%
2021-12-31$A$25.88 B80.55%
2020-12-31$A$14.33 B-9.47%
2019-12-31$A$15.83 B27.42%
2018-12-31$A$12.43 B57.95%
2017-12-31$A$7.86 B27.5%
2016-12-31$A$6.17 B23.03%
2015-12-31$A$5.01 B61%
2014-12-31$A$3.11 B42.39%
2013-12-31$A$2.18 B82.61%
2012-12-31$A$1.19 B152.98%
2011-12-31$A$0.47 B-8.83%
2010-12-31$A$0.51 B17.65%
2009-12-31$A$0.44 B-26.07%
2008-12-31$A$0.59 B13.49%
2007-12-31$A$0.52 B91.58%
2006-12-31$A$0.27 B76.37%
2005-12-31$A$0.15 B-33.95%
2004-12-31$A$0.23 B27.39%
2003-12-31$A$0.18 B-28.53%
2002-12-31$A$0.25 B-50.35%
2001-12-31$A$0.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$121.60 B 167.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$60.02 B 32.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$16.72 B-63.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$113.62 B 150.38%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$26.97 B-40.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.93 B-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA